Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management

Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management

High-grade brain tumors are malignant tumors with poor survival and remain the most difficult tumors to treat. An important contributing factor to the development and progression of brain tumors is their ability to evade the immune system. Several immunotherapeutic strategies including vaccines and...

Full description

Bibliographic Details
Main Authors: Alessia Filippone, Deborah Mannino, Giovanna Casili, Marika Lanza, Irene Paterniti, Salvatore Cuzzocrea, Anna Paola Capra, Lorenzo Colarossi, Dario Giuffrida, Sofia Paola Lombardo, Emanuela Esposito
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
brain tumors
protein kinase inhibitor
immune system
tumor microenvironment
anti-tumor immunity
Online Access:https://www.mdpi.com/1422-0067/23/24/15693

Internet

https://www.mdpi.com/1422-0067/23/24/15693

Similar Items